Summary
We have used ligand blotting and Northern blotting techniques to examine the effects of progestins and antiestrogens on expression of insulin-like growth factor binding proteins (IGFBPs) by T-47D human breast cancer cells under conditions where these agents are growth inhibitory. Under basal conditions, conditioned medium from T-47D cells was found to contain IGFBPs of 39, 33, and 27 kDa. Northern blot and/or Western blot analysis have identified these as IGFBP 2, 5, and 4, respectively. Medroxyprogesterone acetate (MPA) treatment resulted in a time- and dose-dependent decrease in IGFBP 4 and 5 mRNA abundance and secretion of these proteins, while little if any effect was observed on IGFBP 2 expression. A decrease in the steady state mRNA levels for IGFBP 4 and 5 was observed with as little as 0.1 nM MPA. Using 10 nM MPA a maximum decrease in IGFBP 4 and 5 mRNA levels was observed between 12 and 24 hours. While RU 486 alone had little or no effect on IGFBP 4 expression, it inhibited the effect of MPA. However, in the same samples, IGFBP 5 expression was inhibited by RU 486, and RU 486 was unable to reverse the effects of progestins on the expression of IGFBP 5. Furthermore, another synthetic progestin, Org 2058, but not dexamethasone, inhibited IGFBP 4 and IGFBP 5 expression. The antiestrogen ICI 164384 also transiently decreased the steady state mRNA levels of both IGFBP 4 and IGFBP 5. Regulation of expression of the IGFBPs by these agents suggests a potential role for the IGFBPs in the growth response of T-47D cells to these agents.
References
Yee D, Rosen F, Favoni ER, Cullen JK: The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res 53: 93–106, 1991
Papa V, Hartmann KKP, Rosenthal SM, Maddux BA, Siiteri PK, Goldfine ID: Progestin induced down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: Potential autocrine role of IGF-II. Mol Endocrinol 5: 707–717, 1991
Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, Lippman ME, Rosen N: Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol Endocrinol 3: 509–519, 1989
Dickson RB, Lippman ME: Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Rev 8: 29–43, 1987
Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SAW, Ramasharma K, Marshall M, Li CH: Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol 3: 1701–1709, 1989
Karey KP, Sirbasku DA: Differential responsiveness of human breast cancer cell lines MCF-7 and T-47D to growth factors and 17β-estradiol. Cancer Res 48: 4083–4092, 1988
Pollak MN, Polychronakos C, Yousefi C, Richard M: Characterization of insulin-like growth factor I (IGF-I) receptors of human breast cancer cells. Biochem Biophys Res Commun 154: 326–331, 1988
Huff KC, Kaufman D, Gabbay KH, Spencer EM, Lippman ME, Dickson RB: Secretion of insulin-like growth factor-Irelated protein by human breast cancer cells. Cancer Res 46: 4613–4619, 1986
Yee D, Cullen KJ, Paik S, Perdue JF, Hampton B, Schwartz A, Lippman ME, Rosen N: Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res 48: 6691–6696, 1988
DeLeon DD, Bakker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152: 398–405, 1988
Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50: 48–53, 1990
Hsu D, Olefsky JM: Characterization of insulin-like growth factor (IGF) binding proteins and their role in modulating IGF-I action in BHK cells. J Biol Chem 267: 25576–25582, 1992
DeLeon DD, Wilson DM, Bakker B, Lamson G, Hintz RL, Rosenfeld RG: Characterization of insulin-like growth factor binding proteins from human breast cancer cells. Mol Endocrinol 3: 567–574, 1989
Andress DL, Birnbaum RS: A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells. Biochem Biophys Res Commun 176: 213–218, 1991
LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD: Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation. Mol Endocrinol 4: 1806–1814, 1990
DeVroede MA, Tseng LY-H, Katsoyannis PG, Nissley SP, Rechler MM: Modulation of insulin-like growth factor I binding to human fibroblast monolayer cultures by insulin-like growth factor carrier proteins released to the incubation media. J Clin Invest 77: 602–613, 1986
Thrailkill KM, Clemmons DR, Busby WH, Handwerger S: Differential regulation of insulin-like growth factor binding protein secretion from human decidual cells by IGF-I, insulin, and relaxin. J Clin Invest 86: 878–883, 1990
Moser DR, Lowe WL, Dake BL, Booth BA, Boes M, Clemmons DR, Bar RS: Endothelial cells express insulin-like growth factor-binding proteins 2 to 6. Mol Endocrinol 6: 1805–1814, 1992
Sheikh MS, Shao Z-M, Clemmons DR, LeRoith D, Roberts CT Jr, Fontana JA: Identification of the insulin-like growth factor binding proteins 5 and 6 (IGFBP-5 and 6) in human breast cancer cells. Biophys Biochem Res Commun 183: 1003–1010, 1992
Camacho-Hubner C, Busby WH Jr, McCusker RH, Wright G, Clemmons DR: Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267: 11949–11956, 1992
Wood WI, Cachianes G, Henzel WJ, Winslow GA, Spencer SA, Hellmiss R, Martin JL, Baxter RC: Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Endocrinology 2: 1176–1185, 1988
Kiefer MS, Ioh RS, Bauer DM, Zapf J: Molecular cloning of a new human insulin-like growth factor binding protein. Biochem Biophys Res Commun 176: 219–225, 1991
Binkert C, Landwehr J, Mary J-L, Schwander J, Heinrich G: Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J 8: 2497–2502, 1989
Lee Y-L, Hintz RL, James PM, Lee PDK, Shively JE, Powell DR: Insulin-like growth factor (IGF) binding protein complementary deoxyribonucleic acid from human HEP G2 hepatoma cells: Predicted protein sequence suggests an IGF binding domain different from those of the IGF-I and IGF-II receptors. Mol Endocrinol 2: 404–411, 1988
Shimasaki S, Gao L, Shimonaka M, Ling N: Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol Endocrinol 5: 938–948, 1991
Shimasaki S, Shimonaka M, Zhang H-P, Lin N: Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266: 10646–10653, 1991
Hintz RL: Role of growth-hormone and insulin-like growthfactor-binding proteins. Horm Res 33: 105–110, 1990
Krywicki RF, Yee D: The insulin-like growth factor family of ligands, receptors, and binding proteins. Breast Cancer Res Treat 22: 7–19, 1992
Elgin RG, Busby WH Jr, Clemmons DR: An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA 84: 3254–3258, 1987
DeMellow JSM, Baxter RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 156: 199–204, 1988
Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J: Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 267: 12692–12699, 1992
Adamo ML, Shao Z-M, Lanau F, Chen JC, Clemmons DR, Roberts C Jr, LeRoith D, Fontana JA: Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, 3, and -4 gene expression and protein secretion in a breast cancer cell line. Endocrinology 131: 1858–1866, 1992
DeLeon DD, Baker B, Wilson DM, Hintz RL, Rosenfeld RG: Demonstration of insulin-like growth factor (IGF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochem Biophys Res Commun 152: 398–405, 1988
Yee D, Favoni RE, Lippman ME, Powell DR: Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res Treat 18: 3–10, 1991
Murphy LC, Dotzlaw H: Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antistrogens. Cancer Res 49: 599–604, 1989
Murphy LC, Murphy LJ, Dubik D, Bell GI, Shiu RPC: Epidermal growth factor gene expression in human breast cancer cells: Regulation of expression by progestins. Cancer Res 48: 4555–4560, 1988
Gong Y, Ballejo G, Alkhalaf B, Molnar P, Murphy LC, Murphy LJ: Phorbol esters differentially regulate expression of insulin-like growth factor binding proteins in human endometrial carcinoma cells. Endocrinology 131: 2747–2754, 1992
Murphy LJ, Murphy LC, Stead B, Sutherland RL, Lazarus L: Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J Clin Endocrinol Metab 62: 280–287, 1986
Owens PC, Gill PG, DeYoung NJ, Weger MA, Knowles SE, Moyse KJ: Estrogen and progesterone regulate secretion of insulin-like growth factor binding proteins by human breast cancer cells. Biochem Biophys Res Commun 193: 467–473, 1993
Conover CA, Kiefer MC, Zapf J: Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. J Clin Invest 91: 1129–1137, 1993
Clarke CL, Roman SD, Graham J, Koga M, Sutherland RL: Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. J Biol Chem 265: 12694–12700, 1990
Conover CA, Liu F, Powell D, Rosenfeld RG, Hintz RL: Insulin-like growth factor binding proteins from cultured human fibroblasts: Characterization and hormonal regulation. J Clin Invest 83: 852–859, 1989
Giudice LC, Dsupin BA, Irwin JC: Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation. J Clin Endocrinol Metab 75: 1235–1241, 1992
Gao L, Ling N, Shimasaki S: Structure of the rat insulin-like growth factor binding protein-4 gene. Biochem Biophys Res Commun 190: 1053–1059, 1993
Figueroa JA, Yee D: The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res Treat 22: 81–90, 1992
Clemmons DR, Camacho-Hubner C, Coronado E, Osborne CK: Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: Correlation with estrogen receptor status. Endocrinology 127: 2679–2686, 1990
Zhu X, Ling N, Shimasaki S: Cloning of the rat insulin-like growth factor binding protein-5 gene and DNA sequence analysis of its promoter region. Biochem Biophys Res Commun 190: 1045–1052, 1993
May FEB, Westley BR: Effects of tamoxifen and 4-hydroxytamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J Biol Chem 262: 15894–15899, 1987
Meyer M-E, Pornon A, Ji J, Bocquel M-T, Chambon P, Gronemeyer H: Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor. EMBO J 9: 3923–3932, 1990
Huff KK, Knabbe C, Lindsey R, Kaufman D, Bronzert D, Lippman ME, Dickson RB: Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells. Mol Endocrinol 2: 200–208, 1988
Shiu RPC: Prolactin receptors in human breast cancer cells in long term culture. Cancer Res 39: 4381–4386, 1979
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5298, 1979
Thomas PS: Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77: 5201–5205, 1980
Murphy LC, Murphy LJ, Tsuyuki D, Duckworth ML, Shiu RP: Cloning and characterization of a cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J Biol Chem 263: 2397–2401, 1988
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951
Hossenlopp P, Seurin D, Segoria-Quinson B, Hardouin S, Binoux M: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138–143, 1986
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685, 1970
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coutts, A., Murphy, L.J. & Murphy, L.C. Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Breast Cancer Res Tr 32, 153–164 (1994). https://doi.org/10.1007/BF00665766
Issue Date:
DOI: https://doi.org/10.1007/BF00665766